Intravenous Magnesium for Sickle Cell Vasoocclusive Crisis

NCT01197417 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

208

Enrollment

OTHER

Sponsor class

Conditions

Sickle Cell Disease

Interventions

DRUG: Intravenous Magnesium Sulfate
DRUG: Normal Saline Placebo

Sponsor

Medical College of Wisconsin

Collaborators

[object Object]